by University of California, Los Angeles A new UCLA-led study suggests that some people living with long COVID may be able to alleviate certain symptoms by using short-term, self-regulating therapies. The […]
COVID’s Long Haul: Virus Lingers in Blood Years After Infection
Featured Neurology Neuroscience, March 7, 2024 Summary: SARS-CoV-2, the virus responsible for COVID-19, can persist in the blood and tissue of some patients for up to two years post-infection, offering new […]
Study identifies potential cause of long COVID muscle weakness
by University of Malta University of Malta researchers have discovered a potential cause of the persistent and often debilitating symptoms experienced by long COVID-19 patients. The new study published in Biochimica et […]
Pathological sequelae of long-haul COVID
Saurabh Mehandru & Miriam Merad, Nature Immunology volume 23, pages194–202 ( Abstract The world continues to contend with successive waves of coronavirus disease 2019 (COVID-19), fueled by the emergence of viral variants. At the same time, […]
Supreme Court Turns Away COVID-19 Vaccine Appeals
TUESDAY, JUN 25, 2024 – 11:00 PM, Authored by Zachary Stieber via The Epoch Times U.S. Supreme Court justices on June 24 rejected appeals brought over COVID-19 vaccines by Children’s […]
Thousands Believe Covid Vaccines Harmed Them. Is Anyone Listening?
May 3, 2024 Within minutes of getting the Johnson & Johnson Covid-19 vaccine, Michelle Zimmerman felt pain racing from her left arm up to her ear and down to her […]
Comparison of Transient and Persistent Adverse Events After COVID-19 Vaccination: A Retrospective Analysis
Haruka Hikichi • Yuki Fujioka • Akiko Saga • Ken Watanabe • Ryo Hasegawa • Yuki Moritoki • Shigeharu Ueki, Published: June 28, 2024, DOI: 10.7759/cureus.63410 Abstract Objective: Most reported adverse events following COVID-19 vaccination have been transient. However, persistent adverse events may occur […]
Human SARS-CoV-2 challenge uncovers local and systemic response dynamics
Rik G. H. Lindeboom, Kaylee B. Worlock, Lisa M. Dratva, et. al.Nature (2024) Abstract The COVID-19 pandemic is an ongoing global health threat, yet our understanding of the dynamics of early cellular responses to […]
Safety and efficacy of low dose naltrexone in a long covid cohort; an interventional pre-post study.
O’Kelly B 1,2, Vidal L 2, McHugh T 2, et. al. Brain, Behavior, & Immunity – Health, 03 Jul 2022, 24:100485, https://doi.org/10.1016/j.bbih.2022.100485 PMID: 35814187 PMCID: PMC9250701 Abstract Background Up to 37.7% of patients experience symptoms beyond 12 weeks after […]
POST-ACUTE SEQUELAE OF COVID-19: CHARACTERIZATION, COMORBIDITIES, AND BIOMARKERS IN A DIVERSE COHORT
Emily Struttmann, Anish Shah, Matthew Moreida, et. al. doi: https://doi.org/10.1101/2024.06.20.24308901 Abstract Introduction Post-acute sequelae of COVID-19 (PASC) is causing a silent pandemic in the U.S. Gulf South, a part of flyover U.S. where patients are quietly withdrawing […]